Saw Palmetto 580 mg by Solaray — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 VegCap(s) Serving Size

360 Servings

Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Saw Palmetto

580 mg

📊 Market median: 320.0mg (426 products) 📚 24 studies (Tier A: 0, B: 5)

This product: 580mg

Other Ingredients

Cellulose

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (98% of products) Structure/Function (83% of products) Nutrient (17% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Dairy Free

Product Information

🧪 Formulation Notes

True Herbs

Urinary tract support

Dietary Supplement

Non GMO Project Verified nongmoproject.org

Lab Verified

Vegan

Discussion: Native to the Florida peninsula, Saw Palmetto berries have been used traditionally for thousands of years. Saw Palmetto berries contain fatty acids and plant sterols. These phytonutrients have been clinically studied for healthy prostate function. Solaray Saw Palmetto Berries are wild-crafted in the United States.

Additional Information

Non GMO Project Verified nongmoproject.org

Since 1973, we've scoured the globe for the highest quality ingredients, connecting you with the most efficacious supplements that help you live brighter & embrace the moments that matter most.

California Residents Only Warning: Reproductive Harm - www.P65Warnings.ca.gov

100% PCR Bottles

Product Details

UPC / SKU 0 76280 01552 2

DSLD Entry Date 2023-09-25

Product Type Botanical

Form Capsule

Brand Solaray

DSLD ID 296228

Data Updated 2026-04-11

Research Evidence

35 Research Sources

52 Avg Quality Score

15 Meta Analysis

11 Systematic Review

7 Rct

1 Narrative Review

1 Openfda Safety

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2009

PubMed DOI

B Serenoa repens for benign prostatic hyperplasia

Meta Analysis The Cochrane database of systematic reviews 2012

PubMed DOI

B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis

Meta Analysis Investigative and clinical urology 2021

PubMed DOI

B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials

Systematic Review European urology focus 2021

PubMed DOI

B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene

Systematic Review European review for medical and pharmacological sciences 2019

PubMed DOI

B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis

Meta Analysis American journal of men's health 2020

PubMed DOI

B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review

Systematic Review BJU international 2012

PubMed DOI

B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis